A. A. Alexandrov

Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study

Pavel Bogomolov, A. A. Alexandrov, M. V. Macievich et al. · Journal of Hepatology · 2016 · 390 citations

Pharmacy, Internal Medicine, Pharmacotherapy +11

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial

Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov et al. · The Lancet Infectious Diseases · 2022 · 158 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection

Heiner Wedemeyer, Pavel Bogomolov, Antje Blank et al. · Journal of Hepatology · 2018 · 121 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Strength of Word-Specific Neural Memory Traces Assessed Electrophysiologically

A. A. Alexandrov, Friedemann Pulvermüller, Yury Shtyrov · PLoS ONE · 2011 · 70 citations · Full text

Language Studies, Neurobiology, Neuroscience +13

Primary prevention of cardiovascular disease: 3-year intervention results in boys of 12 years of age

A. A. Alexandrov, G. Ya. Maslennikova, Grigori A. Propirnu · Preventive Medicine · 1992 · 54 citations

Medicine, Pediatrics, Preventive Medicine +12